These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3292698)

  • 1. Hepatitis B vaccine produced in yeast.
    Bitter GA; Egan KM; Burnette WN; Samal B; Fieschko JC; Peterson DL; Downing MR; Wypych J; Langley KE
    J Med Virol; 1988 Jun; 25(2):123-40. PubMed ID: 3292698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and immunological analysis of recombinant hepatitis B vaccine.
    Emini EA; Ellis RW; Miller WJ; McAleer WJ; Scolnick EM; Gerety RJ
    J Infect; 1986 Jul; 13 Suppl A():3-9. PubMed ID: 2427590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatitis B vaccine from recombinant yeast.
    McAleer WJ; Buynak EB; Maigetter RZ; Wampler DE; Miller WJ; Hilleman MR
    Nature; 1984 Jan 12-18; 307(5947):178-80. PubMed ID: 6318124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant yeast hepatitis B vaccine.
    Hilleman MR
    Dev Biol Stand; 1986; 63():57-62. PubMed ID: 3527821
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B surface antigen (HBsAg) derived from yeast cells (Hansenula polymorpha) used to establish an influence of antigenic subtype (adw2, adr, ayw3) in measuring the immune response after vaccination.
    Heijtink RA; Bergen Pv; Melber K; Janowicz ZA; Osterhaus AD
    Vaccine; 2002 May; 20(17-18):2191-6. PubMed ID: 12009272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of recombinant hepatitis B vaccine.
    Ohmura T; Ohmizu A; Sumi A; Ohtani W; Uemura Y; Arimura H; Nishida M; Kohama Y; Okabe M; Mimura T
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1172-8. PubMed ID: 2962578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subunit, recombinant and synthetic hepatitis B vaccines.
    Zuckerman AJ
    Scand J Gastroenterol Suppl; 1985; 117():27-38. PubMed ID: 3912963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B surface antigen particles with all four subtypic determinants: point mutations of hepatitis B virus DNA inducing phenotypic changes or double infection with viruses of different subtypes.
    Yamanaka T; Akahane Y; Suzuki H; Okamoto H; Tsuda F; Miyakawa Y; Mayumi M
    Mol Immunol; 1990 May; 27(5):443-9. PubMed ID: 1694959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.
    Itoh Y; Takai E; Ohnuma H; Kitajima K; Tsuda F; Machida A; Mishiro S; Nakamura T; Miyakawa Y; Mayumi M
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9174-8. PubMed ID: 3466181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients.
    McMahon G; Ehrlich PH; Moustafa ZA; McCarthy LA; Dottavio D; Tolpin MD; Nadler PI; Ostberg L
    Hepatology; 1992 May; 15(5):757-66. PubMed ID: 1568715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The essential region for assembly and particle formation in hepatitis B virus surface antigen produced in yeast cells.
    Araki K; Shiosaki K; Araki M; Chisaka O; Matsubara K
    Gene; 1990 May; 89(2):195-201. PubMed ID: 2197186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saccharomyces cerevisiae can release hepatitis B virus surface antigen (HBsAg) particles into the medium by its secretory apparatus.
    Kuroda S; Miyazaki T; Otaka S; Fujisawa Y
    Appl Microbiol Biotechnol; 1993 Nov; 40(2-3):333-40. PubMed ID: 7764388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatitis B virus large envelope protein in Escherichia coli and Saccharomyces cerevisiae.
    Korec E; Korcová J; Palková Z; Vondrejs V; Korínek V; Reinis M; Bichko VV; Hlozánek I
    Folia Biol (Praha); 1989; 35(5):315-27. PubMed ID: 2699291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B surface antigen polypeptide micelles from antigen expressed in Saccharomyces cerevisiae.
    Howard CR; Young PR; Lee S; Dixon J; Zuckerman AJ; McAleer WJ; Lehman ED
    J Virol Methods; 1986 Aug; 14(1):25-35. PubMed ID: 2945830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and assembly of hepatitis B virus surface antigen particles in yeast.
    Valenzuela P; Medina A; Rutter WJ; Ammerer G; Hall BD
    Nature; 1982 Jul; 298(5872):347-50. PubMed ID: 7045698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.
    Fujiyama A; Miyanohara A; Nozaki C; Yoneyama T; Ohtomo N; Matsubara K
    Nucleic Acids Res; 1983 Jul; 11(13):4601-10. PubMed ID: 6306594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of hepatitis delta virus-like empty particles in yeast.
    Wu HL; Chen PJ; Mu JJ; Chi WK; Kao TL; Hwang LH; Chen DS
    Virology; 1997 Sep; 236(2):374-81. PubMed ID: 9325245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.
    Ho JK; Jeevan-Raj B; Netter HJ
    Viruses; 2020 Jan; 12(2):. PubMed ID: 31973017
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B surface antigen particles of subtypes adw and adr, and compound subtype (adwr) in symptom-free carriers in Japan.
    Kanagawa H; Takai E; Tsuda F; Machida A; Kojima M; Ishijima A; Tanaka T; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1992 Aug; 37(4):288-93. PubMed ID: 1383415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of a soluble and secreted antigenic fragment of HBsAg in yeast.
    Baba EH; Berkower I
    Biochem Biophys Res Commun; 1992 Apr; 184(1):50-9. PubMed ID: 1567451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.